News | August 02, 2025
USPTO issues final rejection of Rampart IC's radiation shield patent claims
The request stemmed from a 2024 lawsuit by Rampart alleging Egg Medical had infringed its patent
The request stemmed from a 2024 lawsuit by Rampart alleging Egg Medical had infringed its patent
The newly inaugurated facility bridges this gap by offering metro-grade treatment closer to home
Collaboration to provide hospitals with a comprehensive offering across imaging and treatment for cancer patients requiring radiation therapy
It also secures US $ 10 million for US launch and commercialization
These aprons utilise phase change materials that absorb, store and release heat for optimal thermal comfort
Armlupeg is indicated for decrease the incidence of infection, as manifested by febrile neutropenia, in patients with nonmyeloid malignancies receiving myelosuppressive anti-cancer drugs
The update reflects long-term clinical trial data showing that many patients with mCSCC or laCSCC experienced lasting responses
_256_384.png)
India presents one of the world’s largest untapped opportunities for neurovascular screening
Novartis is the only pharmaceutical company with a dedicated commercial RLT portfolio
New site expands manufacturing footprint to meet future demand; ensures continued on-time delivery rate of >99.9% to patients across western US, Alaska and Hawaii
Subscribe To Our Newsletter & Stay Updated
